Understanding the Implications of Trump's 100% Tariff on Foreign Brand-Name Drugs
On September 28, 2025, President Donald Trump announced a controversial policy that will impose a 100% tariff on foreign brand-name pharmaceuticals starting October 1, 2025. This announcement has left many wondering how it will impact the prices of essential medications, particularly those used for weight loss, asthma, and cancer treatment. As the pharmaceutical industry grapples with this new directive, several pressing questions arise regarding its implications for patients, manufacturers, and the healthcare system as a whole.